Articles

Lenalidomide as salvage treatment for multiple myeloma relapsing after allogeneic hematopoietic stem cell transplantation: a report from the French Society of Bone Marrow and Cellular Therapy

CNRS UMR, 8147, Hôpital Necker-Enfants Malades, Paris, France
CHU Lyon Sud, Pierre Bénite, Paris, France
CHU Lyon Sud, Pierre Bénite, Paris, France
Hôpital St Louis, Paris, France
Hôpital Pitié Salpétrière, Paris Cedex 13, France
Institut Gustave Roussy, Villejuif, France
Hematologie Clinique et Therapie Cellulaire, Hopital Saint-Antoine, APHP, Paris, France
CHU Fort de France, Fort-de-France Cedex, Bordeaux, France
CHU de Bx-Haut Lévêque University Bordeaux 2, Bordeaux, France
Centre Hospitalier Henri Mondor, Créteil, France
CHU Angers, Angers, France
Hôpital Purpan, Toulouse cedex 9, France
Hôpital Hautepierre, Strasbourg, France
CHRU Lille, Lille, France
CNRS UMR, 8147, Hôpital Necker-Enfants Malades, Paris, France;Service d’ Hématologie Adultes, Hôpital Necker-Enfants Malades, Paris, France
CHU de Bx-Haut Lévêque University Bordeaux 2, Bordeaux, France
Hematologie Clinique et Therapie Cellulaire, Hopital Saint-Antoine, APHP, Paris, France;Universite Pierre et Marie Curie, Paris, France;INSERM, UMRs 938, Paris, France
Hematologie Clinique et Therapie Cellulaire, Hopital Saint-Antoine, APHP, Paris, France;Universite Pierre et Marie Curie, Paris, France;INSERM, UMRs 938, Paris, France
Vol. 98 No. 5 (2013): May, 2013 https://doi.org/10.3324/haematol.2012.069328